Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.82 USD | -2.79% | -3.79% | +34.02% |
Financials (USD)
Sales 2024 * | 270M | Sales 2025 * | 120M | Capitalization | 1.86B |
---|---|---|---|---|---|
Net income 2024 * | 77M | Net income 2025 * | 2M | EV / Sales 2024 * | 5.25 x |
Net cash position 2024 * | 442M | Net cash position 2025 * | 677M | EV / Sales 2025 * | 9.87 x |
P/E ratio 2024 * |
27.5
x | P/E ratio 2025 * |
-32.2
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | -2.95% | ||
1 week | -2.87% | ||
Current month | +23.55% | ||
1 month | +15.54% | ||
3 months | +8.93% | ||
6 months | +80.05% | ||
Current year | +35.29% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +9.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 30.78 | -2.93% | 108 774 |
24-05-22 | 31.71 | 0.00% | 571,832 |
24-05-21 | 31.71 | +1.44% | 327,288 |
24-05-20 | 31.26 | +1.69% | 290,664 |
24-05-17 | 30.74 | -3.76% | 441,376 |
Delayed Quote Nasdaq, May 23, 2024 at 12:51 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.29% | 1.86B | |
+64.81% | 62.59B | |
-1.31% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.48% | 26.21B | |
-21.66% | 19.09B | |
+4.85% | 13.08B | |
+25.57% | 12.26B | |
+28.14% | 12.05B |
- Stock Market
- Equities
- PTGX Stock